Navigation Links
ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
Date:4/9/2008

facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.

About the American Red Cross

The American Red Cross (http://www.redcross.org) helps people prevent, prepare for and respond to emergencies. Last year, almost a million volunteers and 35,000 employees helped victims of almost 75,000 disasters; taught lifesaving skills to millions; and helped U.S. service members separated from their families stay connected. Almost 4 million people gave blood through the Red Cross, the largest supplier of blood and blood products in the United States. The American Red Cross is part of the International Red Cross and Red Crescent Movement. An average of 91 cents of every dollar the Red Cross spends is invested in humanitarian services and programs. The Red Cross is not a government agency; it relies on donations of time, money, and blood to do its work. Ms. Mary Elcano is the Acting President and CEO of the American National Red Cross.

About Pathogen Removal and Diagnostic Technologies Inc.

Pathogen Removal and Diagnostic Technologies Inc. ("PRDT") is a joint venture established in April 2002 by The American Red Cross and ProMetic Life Sciences Inc., and allows for the exchange of technology and knowledge between the two organizations. PRDT's main goal is to develop products and devices to remove and detect different pathogens from biological sources. This research augments work that ProMetic, the American Red Cross and PRDT's scientific founders have been conducting independently for many years.

About PRDT Academic Co-founders

Dr. Ruben Carbonell, is the Frank Hawkins Kenan Distinguished Professor of Chemical and Biomolecular Engineering, and Director of the Golden LEAF Biomanufacturing Training and Education Center ("BTEC") at North Carolina State University. Dr. Carbonell's research group identifies small, robust affinity ligands for
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Prometic to present at the American Chemical Society
2. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
3. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
4. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
5. ProMetic provides business update - Over $35 million worth of business secured in January
6. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
7. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
8. PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations
9. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
10. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
11. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Nearly 20,000 medical professionals and healthcare leaders ... Clinical Lab Expo in Chicago ... diagnostic research and technology that will advance medicine and ... of Wednesday, July 30, more than 19,500 attendees had ... Lab Expo, with more than 10,000 of these attendees ...
(Date:7/31/2014)... mapped the sound-processing part of the mouse brain in ... the trees in view. Their imaging technique allows zooming ... mice, and it enabled the team to watch brain ... The results, which represent a step toward better understanding ... 31 the journal Neuron . , In the ...
(Date:7/31/2014)... 2014 Rogne Bioscience, a privately-held biotechnology company ... , has acquired a licence to anti-inflammatory peptides from ... potent anti-inflammatory activity of the peptides was discovered by ... Oxford,s Sir William Dunn School of Pathology. ... $1.5 million in seed financing, is developing a first-in-class, ...
(Date:7/31/2014)... , July 31, 2014 Research ... "Global Genomics Market 2014-2018" report to their ... Genomics is the study of the genetic material ... be a strong basis for the discovery and development ... human diseases or health conditions. Genomics is supported by ...
Breaking Biology Technology:Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3New mapping approach lets scientists zoom in and out as the brain processes sound 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2
... 28 Pharmacopeia,(Nasdaq: PCOP ), an innovator ... therapeutics, today announced advancements for two members,of its ... and,Regulatory Affairs, has been promoted to Senior Vice ... S. David Kimball, Ph.D., Senior,Vice President, Chemistry and ...
... DIEGO, Feb. 28 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ... a,Phase I study of ANA773, the company,s oral TLR7 ... trial is a safety,and tolerability study designed to identify ... to select the dose and,schedule for Phase II trials., ...
... report in the February 28, 2008, New England Journal ... Newborn Screening Program (NENSP) of the University of Massachusetts ... genetic disease, providing what may be the first demonstration ... , The state of Massachusetts has offered universal ...
Cached Biology Technology:Pharmacopeia Announces Management Team Changes 2Pharmacopeia Announces Management Team Changes 3Pharmacopeia Announces Management Team Changes 4Pharmacopeia Announces Management Team Changes 5Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 2Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 3Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients 4Data show a decline in cystic fibrosis since introduction of prenatal carrier screening 2
(Date:7/31/2014)... beneath many of the roughly 156,000 gas stations ... corrosion in parts of underground gas storage tankscorrosion ... of groundwater, a source of drinking water. In ... reported many rapidly corroding gas storage tank components ... associated with use of gasoline-ethanol blends and the ...
(Date:7/31/2014)... models against the highly infectious and virulent bacterium, ... kills approximately 30,000 Americans annually. The research is published ... , In the study, the vaccine protected the ... by C. difficile , as well as from ... the human disease, after only two immunizations. , ...
(Date:7/31/2014)... has been made to help better identify and treat those ... narrowing and enlarging of medium sized arteries in the body, ... organs causing damage. In a new report appearing in August ... scientists provide evidence that that FMD may not be limited ... a connection to abnormalities of bones and joints, as well ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2C. difficile vaccine proves safe, 100 percent effective in animal models 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... and 17 September, in the context of France,s presidency ... GMES 2008, at the Grand Palais. The GMES ... set up to provide services relating to the environment, ... services draw on data - mainly Earth observation data ...
... for oceanic vessels has been impeded by worldwide concerns ... gas emissions that impact the Earth,s climate. A ... examines "Emission Tradeoffs among Alternative Marine Fuels: Total Fuel ... Marine Diesel Oil," in a recent issue of ...
... The 2009 Force Protection Equipment,Demonstration (FPED VII) ... VA, and Marine Corps Base, Quantico, VA, next ... Global War on Terror., The demonstration is ... of commercial off-the-shelf equipment solutions to current,and evolving ...
Cached Biology News:Major European program for the environment under the spotlight in Lille, France 2Fuel emissions from marine vessels remain a global concern 22009 Force Protection Equipment Demonstration Set for Next May 19-21 2
... The epitope is specific for Kir2.1 ... other known protein.,SPECIES REACTIVITIES: The ... bovine, porcine and guinea pig. It ... mouse (17/19 residues) and chick (15/19 ...
... Glutamate is the main excitatory neurotransmitter ... had been considered to act only on ... kainate receptors that are involved in the ... been shown to regulate enzymes producing second ...
Polyclonal Antibody to TRIB1/ SKIP1/ Tribbles 1...
PMA (YPMA-1)...
Biology Products: